- Market Capitalization, $K 3,795,676
- Shares Outstanding, K 30,922
- Annual Sales, $ 311,330 K
- Annual Income, $ -9,020 K
- 60-Month Beta 1.87
- Price/Sales 12.46
- Price/Cash Flow N/A
- Price/Book 5.47
|Period||Period Low||Period High||Performance|
| || |
+18.45 (+17.69%)since 04/29/20
| || |
+20.44 (+19.98%)since 02/28/20
| || |
-58.26 (-32.19%)since 05/29/19
(MENAFN - CDN Newswire) and Forecast to 2027 is the latest research study released by DBMR evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical...
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing...
GW Pharmaceuticals (GWPH) might have registered slower international sales growth from procedural deferrals due to coronavirus pandemic in Q1.
Global Medical Cannabis Market Report by Derivative (Cannabidiol (CBD), Tetrahydrocannabinol (THC), Others), Species (Indica, Sativa, Hybrid), Application (Cancer, Arthritis, Migraine, Epilepsy, Others),...
-- Internationally renowned ophthalmologist, Gerd Auffarth, MD, ranked as one of the "100 most influential personalities in ophthalmology worldwide" in the 2020 Power List published by The Ophthalmologist...
The global antiepileptic drugs (AED) market is set to gain traction from the ever-increasing initiatives by manufacturers for producing novel and generic drugs for patients. Patents of numerous second...
Size, Share, Growth, Trends, Market Analysis by Source Type (Hemp, Marijuana), Distribution Channel (B2B, B2C), End-Use (Medical, Personal use, Pharmaceutical, Wellness), Country (United States, Europe,...
Investors in GW Pharmaceuticals plc saw new options become available this week, for the November 20th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is...
This intelligence report provides a comprehensive analysis of the . This includes Investigation of past progress, ongoing market scenarios, and future prospects. Data True to market on the products, strategies...
GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, along with its U.S. subsidiary Greenwich Biosciences, Inc.,...